TDI-014925
TDI-014925 (Compound 58) is a SARS-CoV-2 methyltransferase nonstructural protein 14 (NSP14) inhibitor with an IC50 of 0.2 nM. TDI-014925 has an antiviral activity with significant microsomal stability and no CYP inhibitory activity. TDI-014925 can be used for COVID-19 research[1].
Product Specifications
CAS Number
3052313-53-5
UNSPSC
12352005
Target
SARS-CoV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
CC1=C(C=C(N1C)C(NCC2=C3C(C=NN3C)=CC=C2F)=O)S(=O)(N4CCC5=NNC=C5C4)=O
Molecular Formula
C22H24FN7O3S
Molecular Weight
485.53
References & Citations
[1]Miller MW, et al. Discovery, Optimization, and Evaluation of Non-Nucleoside SARS-CoV-2 NSP14 Inhibitors. J Med Chem. 2025 Sep 25;68 (18) :19076-19106.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP52612_P050-HRP 100 µL
DHRS1 Antibody - N-terminal region : HRP (ARP52612_P050-HRP)
Sign In for Pricing
View Details MBS6503879-01 0.2 mL
TRPV3, NT (Receptor Potential Cation Channel Subfamily V Member 3) (AP)
Sign In for Pricing
View Details MBS6503879-02 5x 0.2 mL
TRPV3, NT (Receptor Potential Cation Channel Subfamily V Member 3) (AP)
Sign In for Pricing
View Details 043425-Biotin 200 µL
TTC6, CT (TTC6, Tetratricopeptide repeat protein 6) (Biotin) discontinued
Sign In for Pricing
View Details